Unlocking the Value of Personalised Cancer Care
Access to Personalised Oncology in Europe, a new report by LSE consulting commissioned by EFPIA, identifies the barriers to better deployment of personalised cancer treatment for European cancer patients and makes concrete recommendations on how to advance and...
Virtual Meeting: Together against Cancer: How can Europe benefit from breakthroughs in personalised oncology?
A virtual meeting, “How can Europe benefit from breakthroughs in personalised oncology?” is organized by the European Federation of Pharmaceutical Industries and Associations, the London School of Economics (LSE), the European Cancer Patient Coalition...
A silver lining: Could changes forced by the pandemic point to better ways to conduct our clinical trials?
Cancerworld published an article, “A silver lining: Could changes forced by the pandemic point to better ways to conduct our clinical trials?” on 28 October 2020. To read the full article and Prof. Jaap Verweij’s comment, click the following link:...